News | Latest Breaking News Stories & Headlines

Vaccine developers Pfizer and BioNTech plan to roll out the first doses within weeks

Some nations face vaccine wait as West snaps up supply

Hailed this week as a pandemic game-changer, the new Covid-19 vaccine offered countries that had pre-ordered doses a potential escape from a cycle of lockdowns and new waves of sickness and death.

World • 13 Nov 20

Health expert says Phase 3 trials currently under way cannot prove their product will prevent people contracting Covid-19

Covid-19 vaccine expectations unrealistic: BMJ expert

None of the trials of Covid-19 candidate vaccines currently under way are designed to detect a reduction in serious outcomes such as hospitalisation or death, according to a leading public health expert.

Coronavirus • 22 Oct 20

The Sanofi/GSK vaccine combines Sanofi's S-protein Covid-19 antigen and GSK's pandemic adjuvant technology

UK secures 60 million doses of Sanofi/GSK vaccine

The UK has signed a deal for up to 60 million doses of a possible Covid-19 vaccine being developed by Sanofi and GlaxoSmithKline - its fourth such arrangement as the race to tame the pandemic heats up.

Business • 29 Jul 20

Moderna, Pfizer start decisive Covid-19 vaccine trials

Pfizer and Moderna have launched two 30,000-subject trials of Covid-19 vaccines that could clear the way for regulatory approval and widespread use by the end of this year.

Business • 28 Jul 20

Sanofi expects to get approval for the potential Covid-19 vaccine it is developing with GlaxoSmithKline by the first half of next year

Sanofi eyes approval of Covid-19 vaccine by H1 2021

French drugmaker Sanofi said today it expects to get approval for the potential Covid-19 vaccine it is developing with Britain's GlaxoSmithKline by the first half of next year, faster than previously anticipated.

Business • 23 Jun 20

How drugs and vaccines are being designed to fight Covid-19

News about studies into the drug Remdesivir has led bulletins across the world over the last 24 hours. Remdesivir is designed to target a specific process which takes place in a cell infected by the virus that causes Covid-19.

Prime Time • 30 Apr 20

Pfizer is among the many drugmakers in the race to develop a vaccine to end the Covid-19 pandemic

Pfizer sticks to forecast after Q1 profit boost

Pfizer has today reiterated its 2020 forecast after posting a quarterly profit that exceeded estimates on higher sales of breast cancer drug Ibrance and blood thinner Eliquis.

Business • 28 Apr 20

Covid-19 vaccine